Citations

Citations to this article as recorded by  

• Therapeutic Targeting of the Galectin-1/miR-22-3p Axis Regulates Cell Cycle and EMT Depending on the Molecular Subtype of Breast Cancer
  Ju Yeon Kim, Jun Ho Lee, Eun Jung Jung, Young Sim Son, Hee Jin Park, Jae Myung Kim, Taejin Park, Sang-Ho Jeong, Jinkwon Lee, Tae Han Kim, Seon Min Lee, Jeong Doo Heo
  Cells.2025; 14(4): 310.     CrossRef
• Differential functions of RhoGDIβ in malignant transformation and progression of urothelial cell following N-butyl-N-(4-hydmoxybutyl) nitrosamine exposure
  Xiaohui Hua, Ronghao Zou, Xiaoyue Bai, Yuyao Yang, Juan Lu, Chuanshu Huang
  BMC Biology.2023;[Epub]     CrossRef
• Systematic investigation of biomarker-like role of ARHGDIB in breast cancer
  Xiaonan Wang, Xiaomin Bi, Xing Huang, Bijun Wang, Qianying Guo, Zhengsheng Wu
  Cancer Biomarkers.2020; 28(1): 101.     CrossRef
• Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer
  Stefan Steurer, Benjamin Hager, Franziska Büscheck, Doris Höflmayer, Maria Christina Tsourlakis, Sarah Minner, Till S. Clauditz, Claudia Hube-Magg, Andreas M. Luebke, Ronald Simon, Jakob R. Izbicki, Eike Burandt, Guido Sauter, Christoph Fraune, Sören Weid
  Aging.2019; 11(18): 7859.     CrossRef
• Prognostic value of Rho GDP dissociation inhibitors in patients with hepatocellular carcinoma following liver transplantation
  Ming-Chun Lai, Qian-Qian Zhu, Kwabena-Gyabaah Owusu-Ansah, Yang-Bo Zhu, Zhe Yang, Hai-Yang Xie, Lin Zhou, Li-Ming Wu, Shu-Sen Zheng
  Oncology Letters.2017; 14(2): 1395.     CrossRef
• RNA interference-mediated knockdown of RhoGDI2 induces the migration and invasion of human lung cancer A549 cells via activating the PI3K/Akt pathway
  Huiyan Niu, Baogang Wu, Yang Peng, Hongfang Jiang, Yi Zhang, Jiahe Wang, Yifei Zhang, Ping He
  Tumor Biology.2015; 36(1): 409.     CrossRef
• Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors
  Jonathan Hensel, Jason E. Duex, Charles Owens, Garrett M. Dancik, Michael G. Edwards, Henry F. Frierson, Dan Theodorescu
  Molecular Cancer Research.2015; 13(9): 1306.     CrossRef
• Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9
  Marcos A. Muñiz Lino, Yadira Palacios-Rodríguez, Sergio Rodríguez-Cuevas, Verónica Bautista-Piña, Laurence A. Marchat, Erika Ruíz-García, Horacio Astudillo-de la Vega, Ana E. González-Santiago, Ali Flores-Pérez, José Díaz-Chávez, Ángeles Carlos-Reyes, Eli
  Journal of Proteomics.2014; 111: 198.     CrossRef
• Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway
  Weiming Duan, Yaxiang Xu, YuJin Dong, Lili Cao, Jian Tong, Xinwen Zhou
  Journal of Radiation Research.2013; 54(4): 611.     CrossRef
• Expression of a tumor-associated gene, LASS2, in the human bladder carcinoma cell lines BIU-87, T24, EJ and EJ-M3
  QINGHUA ZHAO, HAIFENG WANG, MINGYING YANG, DELIN YANG, YIGANG ZUO, JIANSONG WANG
  Experimental and Therapeutic Medicine.2013; 5(3): 942.     CrossRef
• RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration
  Neveen Said, Marta Sanchez-Carbayo, Steven C. Smith, Dan Theodorescu
  Journal of Clinical Investigation.2012; 122(4): 1503.     CrossRef
• Overexpression of RhoGDI2 Correlates with Tumor Progression and Poor Prognosis in Colorectal Carcinoma
  Xianzheng Li, Jianmei Wang, Xiaojing Zhang, Yuanfeng Zeng, Li Liang, Yanqing Ding
  Annals of Surgical Oncology.2012; 19(1): 145.     CrossRef
• Expression and prognostic significance of a new tumor metastasis suppressor gene LASS2 in human bladder carcinoma
  Haifeng Wang, Jiansong Wang, Yigang Zuo, Mingxia Ding, Ruping Yan, Delin Yang, Changxin Ke
  Medical Oncology.2012; 29(3): 1921.     CrossRef
• The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder
  T Qayyum, G Fyffe, M Duncan, P A McArdle, M Hilmy, C Orange, G Halbert, M Seywright, P G Horgan, M A Underwood, J Edwards
  British Journal of Cancer.2012; 106(6): 1187.     CrossRef
• The faces and friends of RhoGDI2
  Erin M. Griner, Dan Theodorescu
  Cancer and Metastasis Reviews.2012; 31(3-4): 519.     CrossRef
• Breast cancer proteomics reveals a positive correlation between glyoxalase 1 expression and high tumor grade
  MIGUEL A. FONSECA-SÁNCHEZ, SERGIO RODRÍGUEZ CUEVAS, GUILLERMO MENDOZA-HERNÁNDEZ, VERONICA BAUTISTA-PIÑA, ELENA ARECHAGA OCAMPO, ALFREDO HIDALGO MIRANDA, VALERIA QUINTANAR JURADO, LAURENCE A. MARCHAT, ELIZBETH ÁLVAREZ-SÁNCHEZ, CARLOS PÉREZ PLASENCIA, CÉSAR
  International Journal of Oncology.2012; 41(2): 670.     CrossRef
• Reactive Center Loop Moiety Is Essential for the Maspin Activity on Cellular Invasion and Ubiquitin‐Proteasome Level
  Chakkrit Khanaree, Kongthawat Chairatvit, Sittiruk Roytrakul, Ariyaphong Wongnoppavich
  Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.2012; 20(9): 427.     CrossRef
• NFIB is a potential target for estrogen receptor‐negative breast cancers
  Hyeong-Gon Moon, Ki-Tae Hwang, Jeong-Ah Kim, Hee Sung Kim, Min-Joo Lee, Eun-Mi Jung, Eunyoung Ko, Wonshik Han, Dong-Young Noh
  Molecular Oncology.2011; 5(6): 538.     CrossRef